In the version of this article initially published, the label for third bar from the left in Figure 4f (' Anti-IL-6α') was incorrect; the correct label is ' Anti-IL-6Rα' . Also, in the legend for Figure 4f , the description of the treatment conditions for middle four bars ('medium alone, or LPS and anti-IL-6 (MR16-1 or polyclonal antibody), anti-IL-6R (mAb#8)') was incorrect; the correct description is 'LPS alone (Medium), or LPS and anti-IL-6Rα (MR16-1), anti-IL-6 (polyclonal antibody or mAb#8)' . The error has been corrected for the print, PDF and HTML versions of this article. In the version of this article initially published, the fifth author's surname was spelled incorrectly (as 'Sarrami-Fooroshani'). The correct spelling is 'Sarrami-Forooshani' . Also, the cells for the third plot in Figure 1d were identified incorrectly as 'Intesrinal DCs' . The correct label is 'Intestinal DCs' . The errors have been corrected in the PDF and HTML versions of this article.
Erratum: Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment In the version of this article initially published, the labels above the plots in Figure 4b were incorrect (with 'Open chromatin' above the first two columns and 'Closed chromatin' above the second two columns). The correct labeling is 'Open chromatin' above the first column, 'Closed chromatin' above the second column, 'Open chromatin' above the third column and 'Closed chromatin' above the fourth column. The error has been corrected in the HTML and PDF versions of the article.
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